The FDA and Cephalon advised healthcare professionals of warnings added to the prescribing information for Provigil, a drug used to improve wakefulness in patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome and shift work sleep disorder.

The revised prescribing information updates safety information to include warnings regarding serious rash, including Stevens-Johnson Syndrome, and hypersensitivity reactions and psychiatric symptoms.

Rare cases of serious or life-threatening rash have been reported in adults and children worldwide. Psychiatric adverse experiences also have been reported in patients treated with Provigil, the FDA said.

Provigil is not approved for use in pediatric patients for any indication.

 



We're here to help!

We live by our creed of “helping those who need it most” and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked * may be required for submission.


Beasley Allen Law Firm
What is Chantix? Chantix (USA) or Champix (Europe and other countries), known generically as...

The extra mile

I can't thank Beasley Allen enough for their excellent and hard work. At every point, they went the extra mile.

—Kay